Allianzgi Convertible & Income Fund II (NCZ) Is At $6.23 Formed Wedge; Strategic Financial Services Has Upped By $1.66 Million Its Cvs Health (CVS) Position

June 19, 2017 - By Darrin Black

Allianzgi Convertible & Income Fund II (NCZ) formed wedge up with $6.60 target or 6.00% above today’s $6.23 share price. Allianzgi Convertible & Income Fund II (NCZ) has $469.72M valuation. About 40,286 shares traded. Allianzgi Convertible & Income Fund II (NYSE:NCZ) has risen 18.50% since June 19, 2016 and is uptrending. It has outperformed by 1.80% the S&P500.

Strategic Financial Services Inc increased Cvs Health Corporation (CVS) stake by 49.92% reported in 2016Q4 SEC filing. Strategic Financial Services Inc acquired 21,334 shares as Cvs Health Corporation (CVS)’s stock declined 4.23%. The Strategic Financial Services Inc holds 64,069 shares with $5.06M value, up from 42,735 last quarter. Cvs Health Corporation now has $75.85B valuation. The stock rose 0.42% or $0.32 reaching $77.38 per share. About 952,732 shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since June 19, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. As per Thursday, December 17, the company rating was maintained by Oppenheimer. The rating was initiated by UBS with “Buy” on Thursday, October 6. Vetr upgraded CVS Health Corp (NYSE:CVS) on Monday, August 24 to “Buy” rating. On Monday, May 9 the stock rating was maintained by Citigroup with “Neutral”. As per Thursday, May 12, the company rating was maintained by Jefferies. Oppenheimer maintained the shares of CVS in report on Friday, August 28 with “Outperform” rating. The firm has “Neutral” rating by Atlantic Securities given on Monday, February 6. On Monday, November 2 the stock rating was maintained by S&P Research with “Strong Buy”. Deutsche Bank maintained CVS Health Corp (NYSE:CVS) rating on Thursday, August 20. Deutsche Bank has “Hold” rating and $121 target. The firm has “Outperform” rating given on Friday, January 22 by Robert W. Baird.

Since February 1, 2017, it had 0 insider buys, and 7 sales for $40.53 million activity. Boratto Eva C had sold 6,029 shares worth $479,908. 76,494 shares valued at $5.99 million were sold by MERLO LARRY J on Wednesday, February 1. $7.71M worth of CVS Health Corp (NYSE:CVS) was sold by Denton David M. Brennan Troyen A had sold 23,849 shares worth $1.88 million. 14,104 shares valued at $1.13M were sold by Sussman Andrew on Monday, March 13. Roberts Jonathan C also sold $4.90M worth of CVS Health Corp (NYSE:CVS) shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: